Ticker League

EBITDA Margin for Biogen (BIIB)

As of · Reported

Metric

TTM

28.3%

YoY change

+0.64pp

Trough year (2003)

-432.0%

Peak year (2002)

63.8%

EBITDA Margin history chart for Biogen (BIIB) from 1985 to 2025

Latest: 31.6%

EBITDA Margin change chart for Biogen (BIIB) from 1985 to 2025

Latest: +0.64pp

EBITDA Margin history table for Biogen (BIIB) from 1985 to 2025

  • 202531.6%+0.64pp
  • 202431.0%+6.79pp
  • 202324.2%-10.60pp
  • 202234.8%-0.96pp
  • 202135.7%-2.27pp
  • 202038.0%-15.84pp
  • 201953.8%+1.69pp
  • 201852.1%-1.70pp
  • 201753.8%-1.59pp
  • 201655.4%+3.26pp
  • 201552.2%+4.71pp
  • 201447.5%+3.87pp
  • 201343.6%+3.62pp
  • 201240.0%-1.69pp
  • 201141.7%+7.27pp
  • 201034.4%-6.65pp
  • 200941.0%+0.28pp
  • 200840.8%-1.22pp
  • 200742.0%+9.59pp
  • 200632.4%-6.60pp
  • 200539.0%+6.25pp
  • 200432.7%+464.76pp
  • 2003-432.0%-495.78pp
  • 200263.8%+22.46pp
  • 200141.3%-16.00pp
  • 200057.3%+13.58pp
  • 199943.7%+5.12pp
  • 199838.6%-0.17pp
  • 199738.8%+18.52pp
  • 199620.2%+8.14pp
  • 199512.1%+8.17pp
  • 19943.9%-16.89pp
  • 199320.8%-8.04pp
  • 199228.9%+22.67pp
  • 19916.2%-2.99pp
  • 19909.2%+29.18pp
  • 1989-20.0%+22.72pp
  • 1988-42.7%+194.49pp
  • 1987-237.2%+153.42pp
  • 1986-390.6%-202.55pp
  • 1985-188.1%—

EBITDA Margin values are taken from Biogen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Biogen (BIIB)

According to Biogen's latest reported financial statements, the company's latest reported EBITDA margin is 28.3%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual EBITDA margin for Biogen (BIIB) came in at 31.60% – expanded 0.6 percentage points year-over-year.

2002 marks the peak EBITDA margin at 63.76%, with the historical low of -432.02% recorded in 2003.

Biogen EBITDA Margin by Year

Biogen EBITDA Margin 2025: 31.6%

2025's EBITDA margin for Biogen came in at 31.60%, expanded 0.6 percentage points from 2024.

Biogen EBITDA Margin 2024: 31.0%

Biogen posted EBITDA margin of 30.96% in 2024, expanded 6.8 percentage points from 2023.

Biogen EBITDA Margin 2023: 24.2%

In 2023, Biogen reported EBITDA margin of 24.17%, contracted 10.6 percentage points from 2022.

Biogen EBITDA Margin 2022: 34.8%

Biogen EBITDA margin in 2022 was 34.77%, contracted 1.0 percentage points from 2021.

Biogen EBITDA Margin 2021: 35.7%

Biogen EBITDA margin in 2021 was 35.73%.

See more financial history for Biogen (BIIB).

Sector peers by EBITDA Margin

Healthcare peers of Biogen (BIIB), ranked by their latest EBITDA margin

Frequently asked questions

Biogen (BIIB) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

No dividends paid by this company.